Udenafil
- Generic Name
- Udenafil
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H36N6O4S
- CAS Number
- 268203-93-6
- Unique Ingredient Identifier
- L5IB4XLY36
- Background
Udenafil is a new phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED). It has been approved in South Korea and will be marketed under the brand name Zydena. It is not yet approved for use in the U.S., E.U., or Canada.
- Indication
Investigated for use/treatment in erectile dysfunction and hypertension.
- Associated Conditions
- Erectile Dysfunction
- Associated Therapies
- -
Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-02-05
- Last Posted Date
- 2012-09-05
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 46
- Registration Number
- NCT00607282
- Locations
- 🇰🇷
Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath